[Vasculo-thrombocyte hemostasis in arterial hypertension]

Area of Science:

• Vascular Biology
• Hemostasis
• Hypertension Research

Background:

• Arterial hypertension significantly impacts vascular and thrombocyte hemostasis.
• Understanding hemostatic changes in different hypertension models is crucial for thrombosis prevention.

Purpose of the Study:

• To investigate the vascular-thrombocyte hemostasis in spontaneous arterial hypertension (SAH) and renovascular hypertension (RAH) models.
• To compare thrombocyte reactivity, aggregation, and vessel thromboresistance in these hypertension models.

Main Methods:

• Studied hemostasis in genetically determined spontaneous hypertension (SAH) and acute renovascular hypertension (RAH) rat models.
• Assessed thrombocyte reactivity to aggregation inducers.
• Analyzed serotonin, adenine nucleotides, and glycogen content in thrombocytes.
• Evaluated aorta antiaggregation activity.
• Utilized laser-induced thrombosis model to assess thrombogenesis and thromboresistance.

Main Results:

• Hypertensive rats exhibited increased thrombocyte reactivity to aggregation inducers.
• RAH showed accelerated disaggregation, shortening the aggregation response.
• Thrombocytes in hypertensive rats had decreased serotonin, free adenine nucleotides, and glycogen.
• Serotonin exchange was altered, and aorta antiaggregation activity was enhanced.
• SAH model demonstrated enhanced thrombogenesis and reduced vessel thromboresistance.

Conclusions:

• Hypertension significantly alters vascular-thrombocyte hemostasis, affecting platelet function and vessel properties.
• Enhanced thrombogenesis and reduced thromboresistance in SAH may potentiate thrombosis risk.
• Findings highlight the complex role of hemostasis in hypertensive states and thrombosis development.